Anthropic plans to triple its international workforce and grow its applied Artificial Intelligence team fivefold in 2025, stepping up its challenge to OpenAI, Microsoft and Google.

The expansion is fueled by rising global demand, with nearly 80 per cent of usage for its Claude AI platform now coming from outside the United States Markets such as South Korea, Australia and Singapore have already surpassed America in per-capita adoption, according to CNBC.

“Our international growth is outpacing even our most ambitious forecasts,” Chief Commercial Officer Paul Smith said, noting that major clients are coming on board before the company establishes a physical presence.

“What is amazing is we haven’t, up until recently, had significant human presence in Europe, in Japan, in our international markets, and yet we already have a very, very significant business over there.”

Smith noted strong uptake in industries such as life sciences and sovereign wealth management.

At Novo Nordisk, the Danish drugmaker behind Ozempic, Claude was used to cut a drug development analysis and reporting phase from three months to just a few days.

He added that Anthropic is accelerating recruitment across key international markets to meet growing demand.

Anthropic plans to hire country leads in India, Australia and New Zealand, Korea, and Singapore, while broadening its footprint across the U.K., northern and southern Europe, Germany, Austria and Switzerland.

The company is also opening its first Asia office in Tokyo and expanding its European presence, adding more than 100 roles in Dublin and London and establishing a research hub in Zurich.

Further international locations are expected in the coming months.